Ana Radeljevic
Directeur/Bestuurslid bij MERRIMACK PHARMACEUTICALS, INC.
Vermogen: 61 218 $ op 30-04-2024
Actieve functies van Ana Radeljevic
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MERRIMACK PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 06-06-2022 | - |
Independent Dir/Board Member | 06-06-2022 | - | |
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01-09-2021 | - |
Loopbaan van Ana Radeljevic
Eerdere bekende functies van Ana Radeljevic
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
REVVITY, INC. | Corporate Officer/Principal | 01-01-2014 | 01-01-2016 |
Opleiding van Ana Radeljevic
Syracuse University | Masters Business Admin |
Old Dominion University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
REVVITY, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Health Technology |
- Beurs
- Insiders
- Ana Radeljevic
- Ervaring